Biogen Idec Inc (BIIB) Stock Quote

Detailed Quote for Biogen Idec Inc (BIIB)

After Hours: $ 117.9745

-0.1655 (-0.14%)

Volume: 7.13 k

4:39 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

February 2, 2012

Close: 123.23

52 Week Low

February 11, 2011

Close: 65.39

Today

Last Price
118.14

Change $
0.36

Change %
0.31%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
116.98

High
118.16

Low
116.44

Prev Close
117.78

Last Trade
4:00

Volume
1.04 m

52 Wk Hi
123.23

52 Wk Low
65.39

Market Cap
28.2 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
238,725,065

EPS (TTM)
5.04

PE Ratio
23.40

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Biogen Idec Inc (BIIB)

Sector News | Topic News

News for BIIB

Wed, Feb 08, 2012

4:01 PM

Biogen Idec to Present at the Leerink Swann Global Healthcare Conference - Business Wire

Fri, Feb 03, 2012

9:00 AM

2012 Economic Outlook - Report Highlights VIVUS, Inc. and Biogen Idec Inc. - Marketwire

Thu, Feb 02, 2012

8:00 AM

Equity Research on Amgen Inc. and Biogen Idec Inc. - Biotech Industry Growing - Marketwire

Tue, Jan 31, 2012

7:00 AM

Biogen Idec Surpasses $5 Billion in 2011 Annual Revenue - Business Wire

Mon, Jan 30, 2012

8:00 AM

Biogen Idec Appoints Kenneth DiPietro Executive Vice President, Human Resources - Business Wire

Thu, Jan 26, 2012

8:00 AM

ASCEND Study to Evaluate the Effectiveness of TYSABRI® (natalizumab) as a Treatment for Secondary-Progressive Multiple Sclerosis - Business Wire

Fri, Jan 20, 2012

4:40 PM

FDA Updates TYSABRI® (natalizumab) Label to Include Anti-JC Virus Antibody Status as a PML Risk Factor - Business Wire

4:40 PM

FDA Updates TYSABRI® (natalizumab) Label to Include Anti-JC Virus Antibody Status as a PML Risk Factor - Business Wire

4:00 PM

Quest Diagnostics STRATIFY JCV(tm) First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients - PR Newswire

Tue, Jan 17, 2012

9:00 AM

A Forward Look, the Year Ahead - Featured Research on Elan Corporation, plc (ADR) and Biogen Idec Inc. - Marketwire

Fri, Jan 13, 2012

4:37 PM

Biogen Idec to Report Fourth Quarter & Year End 2011 Financial Results on January 31, 2012 - Business Wire

Mon, Jan 09, 2012

9:00 AM

Biogen Idec Presents 2012 Strategic Priorities at 30th Annual J.P. Morgan Healthcare Conference - Business Wire

Wed, Jan 04, 2012

8:30 AM

Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy - Business Wire

Tue, Jan 03, 2012

4:01 PM

Biogen Idec to Present at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire

Wed, Dec 28, 2011

4:01 PM

Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference - Business Wire

Mon, Dec 19, 2011

9:00 AM

ALS Therapy Development Institute Announces Research Agreement with Biogen Idec and UCB to Investigate the Role of CD40L in ALS - PR Newswire

Mon, Dec 05, 2011

10:00 PM

Samsung and Biogen Idec Announce Joint Venture to Develop, Manufacture and Market Biosimilars - Business Wire

Wed, Nov 30, 2011

4:01 PM

Biogen Idec to Present at the 2011 Deutsche Bank BioFEST - Business Wire

8:05 AM

Analytical Reports on Celgene Corporation and Biogen Idec Inc. - Influx of New Products and Uses in Biotech Industry - Marketwire

Tue, Oct 11, 2011

10:24 AM

Emerging companies in the diabetic treatment space rising - Accesswire

More News for BIIB >>

Tags for Biogen Idec Inc

Research stocks or mutual funds related to Biogen Idec Inc by keywords or tags. Find companies that have a similar focus to BIIB. The keywords below have been associated to BIIB by either user submission or electronic means.

nurse careers marketing careers biotechnology company healthcare jobs job search realtor careers elan underwriting jobs multiple sclerosis alternative therapy pharmaceutical market counterfeit products pharmaceuticals companies media training niche pharmaceutical breach of contract law pharma strategy medical product development nursing jobs biotechnology market accounting career pharmaceutical research and development employment contract law mechanic jobs purchasing jobs pharmaceutical manufacturing company health care careers high salary careers Biological Products pharma marketing pharmaceutical industry marketing business contract law hr careers pharmaceutical software pharma manufacturing accounting careers ms symptoms real estate careers pharma license pfizer pharmaceutical company kv pharmaceutical company counterintelligence jobs marketing jobs careers information generic products job multiple sclerosis hyperbaric pharmaceutical cro pharma companies technical jobs medical marketing